United States · FDA National Drug Code directory
Nauzene
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 52389-242_2d7c94e6-382b-1655-e063-6394a90a712d
- Product NDC
- 52389-242
- Form
- TABLET, CHEWABLE
- Composition / generic term
- Sodium Citrate
- Labeler
- Kobayashi Healthcare International, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20000708
- Source listing expiry
- 20261231
Source-listed ingredients
- TRISODIUM CITRATE DIHYDRATE — 230 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (52389-242-10) / 10 TABLET, CHEWABLE in 1 BLISTER PACK · 52389-242-10
- 3 BLISTER PACK in 1 CARTON (52389-242-42) / 14 TABLET, CHEWABLE in 1 BLISTER PACK · 52389-242-42
- 4 BLISTER PACK in 1 CARTON (52389-242-56) / 14 TABLET, CHEWABLE in 1 BLISTER PACK · 52389-242-56
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →